Peer review reports
From: Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
Original Submission |
15 Jul 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
25 Nov 2021 |
Reviewed |
Reviewer Report
|
22 Jan 2022 |
Reviewed |
Reviewer Report
|
17 Feb 2022 |
Author responded |
Author comments - Jae Hee Cheon
|
Resubmission - Version 5 |
17 Feb 2022 |
Submitted |
Manuscript version 5
|
26 Feb 2022 |
Author responded |
Author comments - Jae Hee Cheon
|
Resubmission - Version 6 |
26 Feb 2022 |
Submitted |
Manuscript version 6
|
3 Mar 2022 |
Author responded |
Author comments - Jae Hee Cheon
|
Resubmission - Version 7 |
3 Mar 2022 |
Submitted |
Manuscript version 7
|
11 Mar 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
Publishing |
15 Mar 2022 |
Editorially accepted |
|
27 Mar 2022 |
Article published |
10.1186/s12876-022-02225-w
|
Learn about peer review